H

Hans Biomed Corp
KOSDAQ:042520

Watchlist Manager
Hans Biomed Corp
KOSDAQ:042520
Watchlist
Price: 30 100 KRW Market Closed
Market Cap: 407.3B KRW

Intrinsic Value

The intrinsic value of one Hans Biomed Corp stock under the Base Case scenario is 15 640.05 KRW. Compared to the current market price of 30 100 KRW, Hans Biomed Corp is Overvalued by 48%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15 640.05 KRW
Overvaluation 48%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hans Biomed Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about Hans Biomed Corp?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hans Biomed Corp valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hans Biomed Corp.

Explain Valuation
Compare Hans Biomed Corp to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hans Biomed Corp?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hans Biomed Corp

Current Assets 60.8B
Cash & Short-Term Investments 10.2B
Receivables 21.9B
Other Current Assets 28.7B
Non-Current Assets 69.1B
Long-Term Investments 23.5B
PP&E 41.5B
Intangibles 608.4m
Other Non-Current Assets 3.5B
Current Liabilities 58.1B
Accounts Payable 5.4B
Accrued Liabilities 1.8B
Short-Term Debt 35.3B
Other Current Liabilities 15.6B
Non-Current Liabilities 9.4B
Long-Term Debt 6.7B
Other Non-Current Liabilities 2.7B
Efficiency

Free Cash Flow Analysis
Hans Biomed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hans Biomed Corp

Revenue
85.6B KRW
Cost of Revenue
-32B KRW
Gross Profit
53.6B KRW
Operating Expenses
-53.6B KRW
Operating Income
-314.5k KRW
Other Expenses
-10B KRW
Net Income
-10B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hans Biomed Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Net Margin
33/100
Profitability
Score

Hans Biomed Corp's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hans Biomed Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
36/100
Solvency
Score

Hans Biomed Corp's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hans Biomed Corp

There are no price targets for Hans Biomed Corp.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hans Biomed Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hans Biomed Corp stock?

The intrinsic value of one Hans Biomed Corp stock under the Base Case scenario is 15 640.05 KRW.

Is Hans Biomed Corp stock undervalued or overvalued?

Compared to the current market price of 30 100 KRW, Hans Biomed Corp is Overvalued by 48%.

Back to Top